Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000576026 | SCV000670066 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-03-30 | criteria provided, single submitter | clinical testing | Alterations resulting in premature truncation (e.g.reading frame shift, nonsense) |
Gene |
RCV000657249 | SCV000778979 | pathogenic | not provided | 2017-09-15 | criteria provided, single submitter | clinical testing | This duplication of one nucleotide in MSH6 is denoted c.3622dupT at the cDNA level and p.Ser1208PhefsX7 (S1208FfsX7) at the protein level. The normal sequence, with the base that is duplicated in brackets, is ACAT[dupT]CTCT. The duplication causes a frameshift which changes a Serine to a Phenylalanine at codon 1208, and creates a premature stop codon at position 7 of the new reading frame. Although this variant has not, to our knowledge, been reported in the literature, it is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. Based on currently available information, we consider MSH6 c.3622dupT to be pathogenic. |